Ray, Kausik K.

Lipid lowering with inclisiran: a real-world single-centre experience

Padam, P., Barton, L., Wilson, S., David, A., Walji, S., de Lorenzo, F., Ray, K. K., Jones, B., & Cegla, J. (2022) · Open Heart

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 41

Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol

Colhoun, H. M., Leiter, L. A., Müller-Wieland, D., Cariou, B., Ray, K. K., Tinahones, F. J., Domenger, C., Letierce, A., Israel, M., Samuel, R., et al. (2020) · Cardiovascular Diabetology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 33

Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk?: CETP as a Target to Lower CVD Risk: Suspension of Disbelief?

Hovingh, G. K., Ray, K. K., & Boekholdt, S. M. (2015) · Circulation

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 31

Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: a nationwide survey of 2674 individuals in Hungary

Mark, L., Vallejo-Vaz, A. J., Reiber, I., Paragh, G., Kondapally Seshasai, S. R., & Ray, K. K. (2015) · Atherosclerosis

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 30

Inclisiran in individuals with diabetes or obesity: Post hoc pooled analyses of the ORION ‐9, ORION ‐10 and ORION ‐11 Phase 3 randomized trials

Leiter, L. A., Raal, F. J., Schwartz, G. G., Koenig, W., Ray, K. K., Landmesser, U., Han, J., Conde, L. G., & Wright, R. S. (2024) · Diabetes, Obesity and Metabolism

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 27

Effects of Inclisiran in Patients With Atherosclerotic Cardiovascular Disease

Wright, R. S., Ray, K. K., Landmesser, U., Koenig, W., Raal, F. J., Leiter, L. A., Conde, L. G., Han, J., & Schwartz, G. G. (2024) · Mayo Clinic Proceedings

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 25

Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational study

van de Borne, P., Peeters, A., Janssens, L., Leone, A., Lemmens, R., Verhaegen, A., De Meulemeester, M., Balthazar, Y., Heijmans, S., Calozet, Y., et al. (2024) · Acta Cardiologica

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 22

Low-density lipoprotein cholesterol goal attainment in Germany: Results from the DA VINCI study

Gouni-Berthold, I., Schaper, F., Schatz, U., Tabbert-Zitzler, A., Fraass, U., Sauer, S., & Ray, K. K. (2022) · Atherosclerosis Plus

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 19

An update on inclisiran for the treatment of elevated LDL cholesterol

Barkas, F., & Ray, K. (2024) · Expert Opinion on Pharmacotherapy

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 9

Cost-Effectiveness of Bempedoic Acid in High Cardiovascular Risk Patients with Statin Intolerance: An Analysis of the CLEAR Outcomes Trial

Nicholls, S. J., Ray, K. K., Lincoff, A. M., Sarnes, E., Gillard, K. K., Bloedon, L., Migliaccio-Walle, K., Elsea, D., & Nissen, S. E. (2026) · American Journal of Cardiovascular Drugs

Lipoproteins and Cardiovascular HealthHealth Systems, Economic Evaluations, Quality of Life

Cited by 4

Great debate: fire-and-forget beats personalized lipid-lowering treatment

Tokgozoglu, L., Barkas, F., Ray, K. K., & Gianos, E. (2025) · European Heart Journal

Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research

Cited by 4

Efficacy and safety of inclisiran in patients with established cerebrovascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised clinical trials

Koenig, W., Ray, K. K., Kallend, D. G., Landmesser, U., Leiter, L. A., Schwartz, G. G., Wright, R. S., Garcia Conde, L., Jaros, M., & Raal, F. J. (2021) · European Heart Journal

Lipoproteins and Cardiovascular HealthAcute Ischemic Stroke Management

Cited by 3

Challenges in achieving LDL-C goals: Insights from the Italian SANTORINI study cohort

Arca, M., Calabrò, P., Solini, A., Pirillo, A., Gambacurta, R., Ray, K. K., & Catapano, A. L. (2026) · Nutrition, Metabolism and Cardiovascular Diseases

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 3